Overview

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Status:
Completed
Trial end date:
2017-08-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and efficacy of etanercept in pediatric patients with moderate to severe psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept